Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 15 of 59, showing 10 Applications out of 584 total, starting on record 141, ending on 150

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

141.

ECCT/24/02/09   pionERA
    This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of   giredestrant compared with fulvestrant, both in combination with the investigator's choice of a CDK4/6 inhibitor   (palbociclib, ribociclib or abemaciclib), in participants with estrogen receptor-positive (ER+), human epidermal   growth factor receptor 2-negative (HER2-) advanced breast cancer who have developed resistance to adjuvant   endocrine therapy.   
Principal Investigator(s)
1. Dr Sitna Ali
Site(s) in Kenya
University of Nairobi -Institute of Tropical and Infectious Diseases
 
04-08-2024 View

142.

ECCT/24/01/03   Doxy Short Course
    A Phase 4 Study of a 3-Day Vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection.   
Principal Investigator(s)
1. Jackson Nyangaresi Nyandoro
2. Nelly Rwamba Mugo
Site(s) in Kenya
1. Pwani Research Centre (Mombasa county)
2. KEMRI CCR-PHRD (Nairobi City county)
 
18-06-2024 View

143.

ECCT/24/01/01   SAVIS
    A Phase 1 Clinical Study to Evaluate the Safety and Immunogenicity of a Novel GMMA Vaccine Against Invasive Non-Typhoidal Salmonella in healthy Kenyan adults.      
Principal Investigator(s)
1. ANTHONY SCOTT
Site(s) in Kenya
KEMRI Centre for Geographical Medicine Research Coast
 
15-04-2024 View

144.

ECCT/23/12/05   Annovera Acceptability Study
    Assessing acceptability of Annovera contraceptive vaginal ring use (compared to other contraceptive method use) among women seeking family planning services   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI-CMR-RCTP Nairobi
 
17-03-2024 View

145.

ECCT/24/01/02   AP Implementation Research
    Implementation of WHO recommendations for drugs and approaches to prevent and treat postpartum hemorrhage: a multi-country feasibility, acceptability and cost-effectiveness study   
Principal Investigator(s)
1. Daisy Ruto Jerop Ruto
Site(s) in Kenya
36 public health facilities in Makueni County
 
30-05-2024 View

146.

ECCT/23/12/02   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Dr. Maricianah Onono
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
4. Siaya County Referral Hospital (SCRH) (Siaya county)
5. Kenya Medical Research Institute Center for Microbiology Research (CMR) (Kisumu county)
6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
10-05-2024 View

147.

ECCT/24/03/05   221163 PALISADE
    Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition   
Principal Investigator(s)
1. Grace Mboya
Site(s) in Kenya
KEMRI Kisumu Clinical Research Site
 
10-05-2024 View

148.

ECCT/23/12/01   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Prof Walter Jaoko
2. Dr. Lucas Thina Otieno
3. Prof. Kariuki Simon
4. Dr. Janet Nyawira Oyieko
5. Walter Otieno
6. Onono Dr. Marcianah
7. Dr. Lucas Thina Otieno
8. Prof. Kariuki Simon
9. Dr. Janet Nyawira Oyieko
10. Walter Otieno
11. Onono Dr. Marcianah
Site(s) in Kenya
1. KAVI-Institute of Clinical Research, University of Nairobi (Nairobi City county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
3. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
4. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
5. Siaya County Referral Hospital (SCRH (Siaya county)
6. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
02-05-2024 View

149.

ECCT/24/02/03   MPZ-MAL-01
    A Phase 2a, Multicenter, Open-label, Dose-finding, Dose Escalation Study of Meplazumab in Adult Patients Diagnosed with   Uncomplicated Plasmodium falciparum Malaria       
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. Kenya Medical Research Institute(KEMRI):Siaya Clinical Research Annex (Siaya county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
3. AHERO CLINICAL TRIALS UNIT (Kisumu county)
 
08-03-2024 View

150.

ECCT/23/11/05   Alma Study
    Feasibility clinical study of the Alma system in treating Primary Postpartum Hemorrhage - Alma Study    
Principal Investigator(s)
1. Omondi Ogutu
Site(s) in Kenya
Kenyatta National Hospital
 
02-04-2024 View